title: Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa.
abstract: Alachlor induces olfactory mucosal tumors in rats in a highly ordered temporal process. We used GeneChip analysis to test the hypothesis that histological progression and oncogenic transformation are accompanied by gene expression changes that might yield clues as to the molecular pathogenesis of tumor formation. Acute alachlor exposure caused upregulation of matrix metalloproteinases (MMP)-2 and -9, tissue inhibitor of metalloproteinase-1, carboxypeptidase Z, and other genes related to extracellular matrix homeostasis. Heme oxygenase was upregulated acutely and maintained elevated expression. Expression of ebnerin, related to the putative human tumor suppressor gene DMBT1, progressively increased in alachlor-treated olfactory mucosa. Progression from adenomas to adenocarcinoma was correlated with upregulation of genes in the wnt signaling pathway. Activated wnt signaling was confirmed by immunohistochemical localization of beta-catenin to nuclei of adenocarcinomas, but not earlier lesions. These observations suggest that initiation and progression of alachlor-induced olfactory mucosal tumors is associated with alterations in extracellular matrix components, induction of oxidative stress, upregulation of ebnerin, and final transformation to a malignant state by wnt pathway activation.
authors.affiliation: Departmet of Environmental Health, University of Cincinnati, Cincinnati, Ohio 45267-0056, USA. MaryBeth.Genter@UC.edu
authors.forename: Mary Beth
authors.initials: MB
authors.lastname: Genter
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Burman
authors.forename: Soundarapandian
authors.initials: S
authors.lastname: Vijayakumar
authors.forename: Cathy L
authors.initials: CL
authors.lastname: Ebert
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Aronow
mesh_terms: D000081:Acetamides / Q000494:pharmacology*; D000230:Adenocarcinoma / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic; D003598:Cytoskeletal Proteins / Q000032:analysis; D018450:Disease Progression; D005109:Extracellular Matrix / Q000378:metabolism; D020869:Gene Expression Profiling; D023281:Genomics; D008297:Male; D009669:Nose Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D009831:Olfactory Mucosa / Q000187:drug effects; D020411:Oligonucleotide Array Sequence Analysis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D020318:Rats, Long-Evans; D015534:Trans-Activators / Q000032:analysis; D015854:Up-Regulation; D051176:beta Catenin
chemical_list: D000081:Acetamides; D002273:Carcinogens; C495268:Ctnnb1 protein, rat; D003598:Cytoskeletal Proteins; D012334:RNA, Neoplasm; D015534:Trans-Activators; D051176:beta Catenin; C000188:alachlor